HEALIUS LIMITED — Director's Dealing 2021

Sep 1, 2021

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity HEALIUS LIMITED	Name of entity HEALIUS LIMITED
ABN	24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Jennifer Macdonald
Date of last notice	1 September 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [434 x 297] intentionally omitted <==

----- Start of picture text -----

Direct or indirect interest Direct
Nature of indirect interest
(including registered holder) N/A
Note: Provide details of the circumstances giving
rise to the relevant interest.
Date of change 1 September 2021
No. of securities held prior to
25,000
change
Class Ordinary shares
Number acquired 10,000
Number disposed N/A
Value/Consideration
Note: If consideration is non-cash, provide details $4.99 per share
and estimated valuation
No. of securities held after 35,000
Jennifer Macdonald
change Ordinary shares
----- End of picture text -----

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under On-market purchase dividend reinvestment plan, participation in buyback

Part 2 – Change of director’s interests in contracts Not applicable

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a[+] closed period where prior written N/A clearance was required? If so, was prior written clearance provided to allow the N/A trade to proceed during this period? If prior written clearance was provided, on what date was N/A this provided?

Authorised by: Charles Tilley Company Secretary

Date: 2 September 2021

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011